Coexistence of antinucleosome and anti–double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients
Laboratory Medicine · 2025
DOI: 10.1093/labmed/lmaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Mourad Elghali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology Fattouma Bourguiba Monastir, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Antinuclear, Nucleosomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Introduction
We sought to compare clinical features among distinct antibody profiles defined by the presence or absence of antinucleosome (anti-NCS) and anti–double-stranded DNA (anti-dsDNA) antibodies in Tunisian patients with systemic lupus erythematosus (SLE).
Methods
The study enrolled 131 patients with SLE meeting at least 4 American College of Rheumatology or SLICC criteria. Participants were recruited from the Department of Internal Medicine and Rheumatology at the university teaching hospital of Monastir between January 2000 and December 2022. The patients were divided into 4 groups: Group 1 with neither anti-dsDNA nor anti-NCS; Group 2 with anti-dsDNA and no anti-NCS; Group 3 with anti-NCS lacking anti-dsDNA; and Group 4 with both anti-NCS and anti-dsDNA.
Results
The mean (SD) age at the time of diagnosis for the 131 participants with SLE was 38.7 (15.1) years; the ratio of female to male individuals was 7.2. Thirty-four (26%) patients were positive for anti-NCS and anti-dsDNA (group 4: antinuclear antibody pattern AC-1, 72%; pattern AC-5, 16%), and 30 (22.9%) were positive for anti-NCS and negative for anti-dsDNA (group3: pattern AC-1, 53.6%; pattern AC-5, 32.1%). The group 3 patients showed higher peripheral neuropsychiatric SLE (P =.034) and lower rates of disease activity (P =.01). The comparison between the 4 groups showed that group 4 patients had the highest frequency of lupus nephritis (P ≤.001) and the highest rate disease activity (P =.013).
Discussion
Patients with both anti-NCS and anti-dsDNA at the time of diagnosis are likely to have severe SLE, while anti-NCS was associated with nonsevere disease in patients with SLE who lack anti-dsDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology Fattouma Bourguiba Monastir, University of Monastir, Monastir, Tunisia.
- Department of Rheumatology Fattouma Bourguiba Monastir, University of Monastir, Monastir, Tunisia.
- Department of Internal Medicine Fattouma Bourguiba Monastir, University of Monastir, Monastir, Tunisia.
- Research Laboratory LR12ES05, Lab-NAFS Nutrition-Functional Food and Health Faculty of Medicine Monastir, University of Monastir, Monastir, Tunisia.
- Laboratory of Medical and Molecular Parasitology-Mycology (code LR12ES08), Department of Clinical Biology B, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
ORCID-Profile: Mourad Elghali
Zitieren
APA
Elghali, M., Azizi, M., Jguirim, M., Hammami, S., & Sakly, N. (2025). Coexistence of antinucleosome and anti–double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf002
Vancouver
Elghali M, Azizi M, Jguirim M, Hammami S, Sakly N. Coexistence of antinucleosome and anti–double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients. Laboratory Medicine. 2025. doi:10.1093/labmed/lmaf002
BibTeX
@article{Elghali2025,
author = {Elghali, Mourad and Azizi, Mariem and Jguirim, Mahbouba and Hammami, Sonia and Sakly, Nabil},
title = {Coexistence of antinucleosome and anti–double-stranded DNA antibodies is associated with severe systemic lupus erythematosus in Tunisian patients},
journal = {Laboratory Medicine},
year = {2025},
doi = {10.1093/labmed/lmaf002}
}
EUVIMED